The effect of 3b-hidroxihop-22(29)ene (3-BHO) on insulin and glucagon-like peptide 1 (GLP-1) secretion as well as the mechanism of action of the compound in pancreatic islet on glucose homeostasis was investigated. The data from in vivo treatment show that 3-BHO significantly reduces the hyperglycemia by increasing the insulin and GLP-1 secretion, as well as by accumulating hepatic glycogen in hyperglycemic rats. In rat pancreatic b-cell, 3-BHO stimulates the glucose uptake, insulin vesicles translocation to the plasma membrane and thus the insulin secretion through the involvement of potassium channels (ATP-and Ca 2+ -dependent K + channels) and calcium channels (L-type voltagedependent calcium channels (L-VDCC)). Furthermore, this study also provides evidence for a crosstalk between intracellular high calcium concentration, PKA and PKC in the signal transduction of 3-BHO to stimulate insulin secretion. In conclusion, 3-BHO diminishes glycaemia, stimulates GLP-1 secretion and potentiates insulin secretion and increase hepatic glycogen content. Moreover, this triterpene modulates calcium influx characterizing ATP-K + , Ca
Introduction
The triterpenes are a wide class of metabolites synthesized and distributed in plants and can be found as free acids or aglycones. They are available in a large number of essential oils, resins and waxes and provide a range of commercial products including pharmaceutical agents [1] . Concerning to the structures, the triterpenes are grouped mainly into euphanes, taraxanes, oleananes, lupanes, ursanes, baccharanes and hopanes. In higher plants, their presence depend on the species, season and the environment of cultivation [2, 3] . The species Croton heterodoxus Baillon belongs to the genus Croton, which is part of the Euphorbiaceae family. Many Euphorbiaceae are well known in different parts of the world as toxic and/or medicinal. The diversity of the effects already described is a reflex of the high chemical diversity of this plant group. The genus Croton comprises around 1300 species of trees, shrubs and herbs distributed in tropical and subtropical regions of both hemispheres, including some species that have been used in popular medicine for many applications. The genus is rich in constituents with biological properties and the terpenoids are the predominant secondary metabolite constituents, chiefly diterpenoids. Triterpenoids, either pentacyclic or steroidal, have frequently been reported for Croton species [4] . Taking into account the benefits of triterpenes as potent compounds that may be useful therapy for diabetes mellitus [2, 5, 6 ], few studies demonstrate the mechanism of action of these compounds in specific targets involved on glucose homeostasis.
The glycaemia is highly regulated by glucose uptake in insulin target tissues (muscle and adipose tissue) and endogenous glucose synthesis (liver and kidney) [7] . The glucose metabolism and its control starts in the intestine, where several processes work together in order to guarantee that the diet carbohydrates are efficiently metabolized and absorbed. These processes involves the intestinal enzymes activities such as disaccharidases as well as the presence of the functioning sugar transporters at the enterocytes plasma membrane such as the glucose transporters SGLT1 and GLUT2 [7] [8] [9] . Additionally, the endocrine cells of the intestine presents an important role on glucose metabolism since they synthesize and release hormones (incretins) such as glucagon-like peptide-1-(7-36) amide (GLP-1), a hormone secreted by the intestinal L-cells in response to meals that potentiates the glucose-stimulated insulin secretion (GSIS) and influences the whole body glucose metabolism [10] .
Glucose is the main physiological secretagogue of insulin from pancreatic b-cells [11] . The abrupt increase of blood glucose (from 3 mmol/L to 22 mmol/L) after a meal take to a biphasic glucosestimulated insulin secretion. The first phase of insulin secretion occurs around 5-6 min after stimulation and the second phase of insulin release is characterized by a sustained increase of the hormone over 60 min [12, 7] . The hyperglycemia induces the uptake of glucose at the b-cell through GLUT2 and its metabolism raising the ATP/ADP ratio. The high intracellular ATP levels closes ATP-dependent potassium channels (K ATP channels) at the plasma membrane and triggers a membrane depolarization that results in the opening of the membrane voltage-activated Ca 2+ channels (L-VDCC) increasing calcium influx to the b-cells [13] . The high cytosolic Ca 2+ promotes the insulin secretory granules translocation and exocytosis culminating on the increase of insulin secretion. The insulin vesicles translocation and exocytosis involves a soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) fusion machinery that can be modulated by different second messengers depending on which kind of signal pathway are activated and or modulated on b-cells. Several kinase substrates have been localized to b-cell secretory vesicles or membrane fractions, which might be involved in vesicle trafficking, priming, and fusion processes which are demonstrated to be regulated by the PKA and PKC signaling pathways [14] [15] [16] [17] . In recent years, there has been a growing interest in antidiabetic agents from natural sources, especially those derived from plants, because the compounds of plants with ethnomedicinal backgrounds in a general way have low toxicity and few side effects than synthetic medicines [18, 19, 5] . Therefore, the aim of the present study was to investigate the role of 3-BHO on glycaemia and the mechanism of action on insulin vesicles translocation and insulin secretion by b-cell. In addition, the toxicity evaluation was carried out in in vivo and in vitro approaches over the time of experiments.
Materials and methods

Chemicals
Bovine serum albumin (BSA), sitagliptin phosphate monohydrate, collagenase Type V, 1,2-bis(2-aminophenoxy)ethane-N,N,N 0 , N 0 -tetraacetic acid tetrakis (acetoxymethyl ester) (BAPTA-AM), nifedipine, apamin, diazoxide, glibenclamide, stearoylcarnitine chloride (ST), N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Regular human insulin (100 IU/mL; Humulin) was purchased from a commercial source. -30) . This compound was previously isolated from Euphorbia lathyris [20, 21] and Rhododendron lepidotum [23] but it is the first time that this compound was isolated and identified at C. heterodoxus. A representative HPLC chromatogram of the triterpene 3-BHO is included as Supplementary material. Briefly, the homogeneity of the triterpene 3-BHO was determined by HPLC on an Agilent 1260
Infinity using a 4.6 mm Â 150 mm Â 5 mm Phenomenex Luna C18
column. The column temperature was maintained at 25 C and the flow rate was 0.5 mL/min. Mobile phase was acetonitrile and water [70:30] as an isocratic method. The triterpene was detected using a diode array detector at 210 nm.
Animals
Male albino Wistar rats, 50-55 days old (180-210 g), were used. Rats were bred in animal facility and housed in an air-conditioned room (approximately 21 C) with controlled lighting (lights on from 06:00 to 18:00 h). The animals were maintained with pelleted food (Nuvital, Nuvilab CR1, Curitiba, PR, Brazil), while tap water was available ad libitum. Fasted rats were deprived of food for 16 h but allowed free access to water. All the animals were carefully monitored and maintained in accordance with the local Ethical Committee for Animal Use (Protocol CEUA-UFSC PP00414).
Oral glucose tolerance curve
Fasted rats were divided into seven groups of six animals. Group I, normal rats; group II hyperglycemic rats that received glucose (4 g/kg; 8.9 M -glucose concentration necessary to induce the hyperglycemic status); group III, hyperglycemic rats that received the vehicle, 2.5% Tween 80; group IV, hyperglycemic rats that received 0.1 mg/kg of compound 3-BHO; group V, hyperglycemic rats that received 1 mg/kg of compound 3-BHO; group VI, hyperglycemic rats that received the 10 mg/kg of compound 3-BHO; group VII, hyperglycemic rats that received 0.05 IU of insulin by i.p. route (positive control group). The glycaemia was measured before any treatment (zero time). Immediately, rats received the treatment (vehicle or 3-BHO) and after 30 min they were overloaded with glucose. The glucose tolerance curve was initiated just after the glucose overload and then the glycaemia was measured at 15, 30, 60 and 180 min. All treatments were administered by oral gavage. Blood samples from the tail vein were collected, centrifuged and the serum was used to determine the glycaemia by the glucose oxidase method [24] and the insulin levels.
Insulin serum measurements
The insulin levels were measured by ELISA according to the manufacturer's instructions. The range of values detected by this assay was 0.2-10 ng/mL. The intra-and inter-assay coefficients of variation for insulin were 3.22 and 6.95, respectively, with a sensitivity value of 0.2 ng/mL. Insulin levels were estimated by means of colorimetric measurement at 450 nm with an ELISA plate reader (Organon Teknika, Roseland, NJ, USA) through interpolation from a standard curve. Samples were analyzed in duplicate and results were expressed as ng of insulin serum mL
À1
. Analyses of area under curve (AUC) obtained during oral glucose tolerance curve (from zero to 60 min), were used to calculate insulinogenic index (Dins/Dgluc) [25, 26] .
GLP-1 serum measurements
For measurements of GLP-1 serum levels, fasted rats were divided into two groups of six animals: group I, rats that received only sitagliptin 10 mg/kg (control); and group II, rats that received sitagliptin 10 mg/kg and 3-BHO 10 mg/kg; sitagliptin and 3-BHO were administered 60 min and 30 min before the oral hyperglycemia induction (Glucose 8.9 M p.o.), respectively. The blood was collected at 0, 15, 30 and 60 min after hyperglycemia induction, centrifuged and the serum obtained used for measurement of GLP-1 by ELISA, in according to the manufacturer's instructions. The range of values detected by this assay was 4.1-1000 pM. The intraand inter-assay coefficients of variation for GLP-1 were <5% and <12%, respectively, with a sensitivity value of 1.5 pM. The GLP-1 level was estimated by means of absorbance measurement at 450 and 590 nm. Samples were analyzed in duplicate and results were expressed as pM of GLP-1 serum [27] .
Glycogen content measurements
The liver without perfusion was harvested from normal rats, hyperglycemic and hyperglycemic rats treated with 3-BHO (0.1, 1.0 and 10 mg/kg by oral gavage) and the glycogen content was immediately determined after 180 min of glucose overload (4 g/ kg). The glycogen was isolated from the tissue as described by [28] and the results were expressed as mg of glycogen/g of tissue [5] .
Pancreatic islet isolation
The rat pancreas was visualized by way of a central abdominal incision. The bile duct was clamped at the tip of the duodenum and cannulated at a point sufficiently proximal to the liver. Krebs Ringer-bicarbonate buffer with a composition of 122 mM NaCl, 3 mM KCl, 1.2 mM MgSO 4 , 1.3 mM CaCl 2 , 0.4 mM KH 2 PO 4 , and 25 mM NaHCO 3 supplemented with 8 mM HEPES (KRb-HEPES) medium was introduced slowly into the bile duct by syringe until the pancreas was clearly distended. The pancreas was then gently removed and then kept in Petri dishes with KRb-HEPES medium. The pancreatic tissue was cut into small pieces (ca. 2 Â 2 mm) and incubated in plastic tubes in 1 mL of KRb-HEPES medium supplemented with collagenase (3 mg). After incubation the mixture was transferred to a conical tube (110 Â 15 mm), resuspended in 10 mL of KRb-HEPES collagenase free medium and centrifuged at room temperature for 3 min at 45 Â g in an Excelsa Baby centrifuge (model 206), FANEM, São Paulo, SP, Brazil. The supernatant was discarded and the sediment resuspended in fresh KRb-HEPES medium. This washing procedure was repeated five times; in the last two washings the islets were allowed to settle without centrifugation. Aliquots (100 mL) of the final sediment with the isolated islet were transferred to the tubes with the incubation medium KRb-HEPES [29, 30] . , 10 À6 M) was added to each sample during the incubation period (10 or 30 min). Samples were processed accordingly [25] . Aliquots were used for the total Table 1 The ratio of cytoplasmic insulin vesicles per b-cell in the presence of 3-BHO protein quantification by the [31] and results were expressed as nmol glucose units/mg of protein.
Calcium uptake experiments
The isolated islets were pre-incubated for 60 min in a Dubnoff metabolic incubator to equilibrate in KRb-HEPES buffer containing 5 mM glucose and 0.1 mCi/mL 45 
Ca
2+ at 37 C, pH 7.4 and gassed with O 2 :CO 2 (95:5; v/v). The time-course of calcium influx in the presence of 100 nM 3-BHO or KRb-HEPES buffer (basal) was carried out at 30, 60, 300, 600 and 900 s. After that, the islets were incubated for 10 min in KRb-HEPES without (basal) or with the 3-BHO (10
À10
, 10 À9 ,10
À8
, 10
À7
, 10 À6 M). In some experiments, channel
antagonists, channel agonist, chelant of calcium or protein kinases inhibitors were added during the last 15 min of incubation before the treatment and maintained during the entire incubation period (see). The following drugs were used: glibenclamide (20 mM) [30] , apamin (0.1 mM) [32] , diazoxide (250 mM) [30] , nifedipine (1 mM) [30, 33] , BAPTA-AM (50 mM), H-89 (10 mM) [34] , and ST (0.1 mM) [35] . The incubation was halted using the technique reported by [36] with modifications [30] . Cold buffer (1 mL with lanthanum chloride (10 mM) at 2 C was added to the samples to stop calcium 
Transmission electron microscopy
For the observation under the transmission electron microscope (TEM), pieces of rat pancreas were incubated in the presence of 3-BHO (100 nM) for 5 or 20 min and were fixed overnight with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) plus 0.2 M sucrose [37] . The material was post-fixed with 1% osmium tetroxide for 3 h, dehydrated in a graded acetone series and embedded in Spurr's resin. Then, thin sections were stained with aqueous uranyl acetate followed by lead citrate according to Reynolds [38] . Four replicates were prepared for each Fig. 1 . Triterpene improves glucose tolerance curve and stimulates GLP-1 secretion. Values are expressed as mean AE S.E.M. with n = 5. Significant at ***p 0.001 and **p 0.01 compared to the respective value for hyperglycemic basal group. experimental group; two samples per replicate were examined under TEM (Jeol JEM1011 at 80 kV) at the Central Laboratory of Electron Microscopy (LCME, UFSC, Brazil). In order to evaluate the ratio of cytoplasmic insulin vesicles per b-cell [39] , an isolated islet was sectioned and the vesicles of b-cells were counted. So, the total number of vesicles was divided by the number of b-cells in the islet. Similarities based on the comparison of individual treatments with replicates suggested that the ultra-structural analyses were reliable (Table 1) .
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Calcium serum measurements and lactate dehydrogenase
Blood samples and the serum were used to determine extracellular lactate dehydrogenase (LDH) after 180 min of oral 3-BHO in vivo treatment (10 mg/kg). KRb solution was also used to determine extra and intracellular LDH after 10 min of in vitro treatment (100 nM). Calcium serum levels were determined at zero and 180 min after 10 mg/kg 3-BHO oral treatment or in the absence in the hyperglycemic basal group. The calcium determination was measured according to the manufacturer's instructions [5] .
Data and statistical analysis
Data were expressed as mean AE S.E.M. One and two-way analysis of variance (ANOVA) followed by Bonferroni post-test or unpaired Student's t-test were used to determine whether there were significant differences between groups. Differences were considered significant at p 0.05. and 10 mg/kg). The acute effect of the compound was able to decrease significantly the serum glucose levels in all doses tested during the period studied when compared with the respective hyperglycemic basal group. The sustained effect on serum glucose lowering was observed with 1 and 10 mg/kg with triterpene 3-BHO treatment improving significantly the glucose tolerance. Also, insulin diminished significantly the serum glucose levels when compared to the hyperglycemic control group over the period studied. As expected, the vehicle 2.5% Tween 80 did not modify the glycemia over the period studied when compared to the hyperglycemic basal group. Also, as it was expected, the euglycemic control group did not show a significant change on the profile of glycemia over the time studied. In percentage terms, the highest reductions on glycemia were detected at the shorter periods (15 and 30 min) after the treatment with 0.1 and 1 mg/kg of triterpene 3-BHO (around 16% and 17%, around 35% and 27%, respectively). This rapid effect on glycemia seems to be supported by an acute action of the compound at the intestinal level, since the serum GLP-1 levels were significantly increased at 15 min, compared with the hyperglycemic plus sitagliptin positive basal group (Fig. 1C) .
Results
Effect of 3-BHO on glycemia and on GLP-1 secretion
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Effect of 3-BHO on insulin secretion and insulin vesicles translocation
Taking into account the antihyperglycemic effect of triterpene 3-BHO after the in vivo treatment, the serum insulin levels were determined in fasted rats after an oral glucose overload. As it was expected, glucose induced-insulin secretion corroborated the classical secretagogue effect of glucose. In addition, the treatment with 3-BHO significantly potentiated the insulin secretion induced by glucose over the time evaluated. Interestingly, the increases of 8%, 20% and 10% of insulin secretion in the presence of 3-BHO were maintained invariable during all the period studied, demonstrating a sustained insulin secretion ( Fig. 2A) , with an insulinogenic index (II) about 0.56 ng/dL (control) and 0.754 ng/dL (3-BHO).
The participation of 3-BHO on the insulin vesicles translocation to the plasma membrane of b-cells was highlighted by electronic microscopy approach. The representative picture (Fig. 2B , panels (a) and (b)) shows the insulin granules accumulated around the plasma membrane in the basal group. After the pancreatic islets incubation with 100 nM of triterpene 3-BHO during 5 min it was observed an increase on insulin granules release (around 70%) when compared with the respective hyperglycemic basal group (panel c). Additionally, after 20 min of incubation in the presence of 3-BHO, the secretion of insulin granules released from b-cells was around 88% compared with the respective hyperglycemic basal group (panel d) ( Table 1 ). Fig. 3 shows the effect of 3-BHO after the in vivo treatment on hepatic glycogen content. All doses of 3-BHO administered by oral gavage increased significantly the glycogen content in the liver measured at 3 h after treatment. 14 
Effect of 3-BHO on hepatic glycogen content
Effect of 3-BHO on
C-glucose uptake on pancreatic islets
The glucose uptake by GLUT2 and its metabolism has a central role in glucose-induced insulin secretion in b-cells. Fig. 4A shows that 3-BHO (10 nM) acutely stimulates glucose uptake in pancreatic islets at 10 and 30 min of incubation. Furthermore, 3-BHO exhibited a bell-shape dose-response curve on glucose uptake at pancreatic islets and its effect was significant from 10 À9 to 10 À6 M after 30 min of pancreatic islets incubation (Fig. 4B) .
Effect of 3-BHO on 45
Ca 2+ influx on pancreatic islets
The ionic intracellular calcium augment is mandatory for insulin secretion by b-cells. So, the role of 3-BHO on calcium influx and the mechanism of action of the compound on insulin secretion were carried out in isolated pancreatic islets. After the calcium equilibrium obtained through 60 min of islet incubation with 45 Ca 2 + , calcium influx was then measured at 30 s and at 1, 5, 10 and 15 min without (basal) or with 3-BHO (100 nM). A stimulatory effect of 3-BHO on calcium influx was observed in a typical spike of calcium influx at 10 min, compared with the respective basal group (Fig. 5A) . The dose that exhibited a significant calcium influx (around 68%) was used for the further in vitro studies (Fig. 5B ).
3.6. Involvement of potassium channels on the stimulatory effect of 3-BHO on 45 
Ca
2+ influx
To study the involvement of K + channels in the stimulatory effect of 3-BHO on calcium influx in pancreatic islets, 20 mM glibenclamide (an ATP-K + potassium channel blocker) and 0.1 mM apamin (a Ca 2+ -K + channel blocker) and 250 mM diazoxide (a potassium channel activator), were used. As expected, glibenclamide significantly increased the calcium influx after 10 min of in vitro incubation. Additionally, during the incubation of the pancreatic islets with 3-BHO in the presence of glibenclamide any additional stimulatory effect on calcium influx was observed (Fig. 6A) . Furthermore, Fig. 6B shows that apamin did not change the basal calcium influx. However, the stimulatory effect of the triterpene on calcium influx in the presence of apamin was completely blocked. Also, diazoxide significantly decreased the calcium influx stimulated by 3-BHO on isolated pancreatic islets (Fig. 6C) .
3.7. Involvement of calcium on the stimulatory effect of 3-BHO on 45 
Ca
2+ influx
Additionally, the implication of L-type voltage-dependent calcium channels (L-VDCCs) in the mechanism of action of 3-BHO on calcium influx on pancreatic islets was studied. Fig. 7A shows that nifedipine did not change the basal level of calcium influx. However, nifedipine nullified the stimulatory effect of 3-BHO on calcium influx.
The influence of calcium from intracellular stocks on the stimulatory effect of 3-BHO in calcium influx was studied by using an intracellular calcium chelator, BAPTA-AM. Fig. 7B shows that BAPTA-AM did not alter the basal level of calcium uptake. However, the equilibrium of calcium from stocks is crucial for the complete stimulatory effect of 3-BHO on calcium influx since on presence of the calcium chelator the stimulatory effect of 3-BHO was completely blocked.
3.8. Influence of protein kinase A and C on the stimulatory effect of 3-BHO on 45 Ca 2+ influx
Involvement of PKA and PKC in triterpene-induced calcium influx at isolated pancreatic islets were carried out. The treatment of rat islets either with H-89, an inhibitor of PKA catalytic activity, or with ST, an inhibitor of PKC activity, nullified the stimulatory effect of 3-BHO on calcium influx. These results showed that the inhibitors used did not change the basal level of calcium influx (Fig. 8) .
Effect of 3-BHO on LDH and calcium serum levels
In order to verify a potential toxicity of this compound, the LDH and calcium serum levels were evaluated after the oral treatment with 3-BHO. The dose of 10 mg/kg orally administrated was not able to change neither serum LDH nor calcium serum levels ( Fig. 9A and B) , indicating that in this experimental condition the 3-BHO administration by oral gavage was not able to exhibit toxic effects. Additionally, the in vitro effect of 3-BHO on intra (Fig. 9C) and extracellular (Fig. 9D ) LDH activity was evaluated after incubation of 3-BHO (100 nM) for 10 min. From these data it was detected that lactate was not accumulated in pancreatic islet and 3-BHO was not toxic in this experimental condition.
Discussion
The compound 3-BHO is a triterpene isolated for the first time from C. Heterodoxus leaves and recently identified by [40] . The antidiabetic effect of 3-BHO in an acute oral treatment was characterized by improving the glucose tolerance curve and its efficiency on insulin secretion. In addition, 10 mg/kg 3-BHO exhibited a profile of serum glucose lowering similar to that observed for the insulin positive control. This effect on glucose homeostasis is in line with those described for oleanolic acid and b-amyrin and recently also for betulinic and ursolic acids studied in a similar approach [41, 42, 5, 6] . The increased insulin release as well as the sustained high insulin levels throughout the period studied induced by 3-BHO in hyperglycemic rats seem to be potentiated by GLP-1 secretion during the transit of this triterpene on intestine. The increase on GLP-1 serum levels measured just after 3-BHO oral treatment may be related with the potentiated insulin secretion detected from 15 to 60 min. This hormone is a potent incretin synthetized and secreted by L-cells type in intestine in response to meals and acts on b-cells stimulating the insulin secretion [43] . Also, 3-BHO was able to accumulate hepatic glycogen content in a short-term effect similar of those reported for other triterpenes, reinforcing their influence on carbohydrate metabolism [44, 45, 5, 6] .
In a whole, the present data point that the triterpene 3-BHO can exert its effects reducing serum glucose levels by influencing GLP-1 and insulin secretion. These results are reinforced by the triterpene's stimulatory effect on insulin granules translocation. It worthwhile to pay attention that the insulinogenic index of 3-BHO (II = 0.754 ng/dL) points to a potential insulin secretagogue when compared to both, the insulinogenic index (II) of the hyperglycemic control group as well as to the lupane-type triterpene betulinic acid group (II = 0.61 ng/mL), measured in a similar approach [5] .
The b-cells are highly sensitive to the elevation of extracellular glucose levels and efficiently take up glucose. Inside the cell, the glucose is efficiently metabolized resulting in an increase of the ATP/ADP ratio that affects the activity of diverse potassium and calcium membrane channels [7] . The stimulatory effect of 3-BHO on glucose uptake (Fig. 4A ) is in accordance to the sustained insulin serum levels ( Fig. 2A ) and the involvement of K ATP channels on the calcium influx at pancreatic islets shown in Fig. 6A -C. These results are in line with the classical pattern of insulin secretion observed in perfused rat pancreas and also reported for human subjects in response to high glucose [47, 48, 49] .
Among the several kind of potassium channels expressed in the pancreatic b-cell the ones critical to insulin secretion are the K ATP channel, the Ca 2+ -K + channel and the delayed rectifier channel Kv [50] . The participation of K ATP channels was well evidenced by using glibenclamide and these results were corroborated when the action of 3-BHO was completely blocked in the presence of diazoxide. Also, the influence of Ca
2+
-K + channels on the signal transduction of 3-BHO was characterized since apamin abrogated the stimulatory effect of 3-BHO on calcium influx. The abrupt increase in intracellular calcium (by influx and from stocks) induced by 3-BHO is in agreement with the ionic events characterized by triggering cellular secretion [51] . The involvement of extracellular calcium mediated by the activation of voltage-dependent Ca 2+ channels, mainly the dihydropyridine sensitive L-type Ca 2+ channels contributes to a localized intracellular calcium concentration that also can be strongly augmented by calcium from stocks to culminate on insulin vesicles exocytosis and insulin secretion [49, 51, 52] . It has already been proved that these potassium and calcium channels are involved on the classical mechanism of the glucose induced insulin secretion. Considering that, compounds that can act through cellular targets that are physiologically involved in the insulin secretion such it is described in the literature [43, 41, 46, 5] and we observed to the triterpene 3-BHO at the present study represent a potential tool to the management of the glucose homeostasis. Despite the well-known depolarization-secretion coupling initiated by the metabolism of glucose, it is also possible activate intracellular signaling pathways that lead to the activation of protein kinases such as PKC and PKA. Besides these protein kinases modulate cell excitability, calcium influx and gene expression recently they have been described as modulators of the secretory secretion by increasing the total number of vesicles that are available for release [53, 54] . Also, increased intracellular calcium activates PKC isoenzymes and release insulin. In addition, glucose also activates PKC directly leading to the insulin release [55, 56] . The participation of PKA and PKC on signal transduction of 3-BHO on pancreatic islets for the release of insulin granules seem to be evident since the calcium influx was completely blocked in the presence of respective and selective inhibitors. These results suggest that 3-BHO can act to stimulate insulin secretion through different pathways involving the modulation of ionic channels as well as a crosstalk between proteins kinases signaling used to modulate the secretory machinery in pancreatic b-cells apparently without cellular toxicity or hypercalcemia after in vivo treatment.
Conclusions
In an oral and acute treatment triterpene 3-BHO diminishes glycaemia, stimulates GLP-1 secretion, and potentiates insulin secretion and significantly increase hepatic glycogen content. Moreover, compound 3-BHO modulates intracellular calcium (by influx and from stocks) characterizing ATP-K + , Ca 2+ -K + and L-VDCC channels-dependent pathways as well as PKA and PKC activity in pancreatic islets underlying the signaling of 3-BHO for the secretory activity and contribution for glucose homeostasis.
